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Rothia dentocariosa is a rare cause of endocarditis. It occurs most frequently in patients
with prior heart conditions. Although the clinical course is typically subacute, it has a
high rate of complications. In particular, the reported incidence of mycotic aneurysms is
as high as 25%. Penicillin is the treatment of choice, but additional complications may
necessitate prompt surgical intervention. As far as we know, this paper reports the ﬁrst
case of repeated subarachnoid hemorrhages due to R. dentocariosa endocarditis.
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INTRODUCTION
In 1967, the genus Rothiawas created to classify the
bacterium until then known as Actinomyces dento-
cariosus, Nocardia dentocariosus or Nocardia salivae
[1]. Rothia dentocariosa is a common inhabitant of
the cavities of the human mouth and throat [2,3].
The bacterium was ﬁrst isolated from carious
lesions [4]. However, since 1975 there have been
several reports of serious infections due to R.
dentocariosa [5]. The most serious infection asso-
ciated with R. dentocariosa is infectious endocardi-
tis (IE), although R. dentocariosa is a rare cause of IE
[6–21].
We report a case of IE caused by R. dentocariosa
with an unusual presentation and a complicated
course. Nineteen previously reported cases are
reviewed.
CASE REPORT
A 17-year-old girl was admitted to the hospital
because of severe frontal headache of sudden
onset. She was known to have impaired function
of the aortic valve as a consequence of a congenital
bicuspid valve, for which she had undergone open
valvotomy at the age of 4 and percutaneous dilata-
tion at the age of 13. Two months before admis-
sion, the patient developed a low-grade fever,
malaise, and an erysipeloid lesion on her leg. At
ﬁrst she was treated by her general practitioner
with clometocillin, an oral penicillin, and subse-
quently with amoxicillin–clavulanic acid. Both
treatments failed to resolve the symptoms deﬁni-
tively, after an initial response.
On admission, the patient was pale and somno-
lent. She showed meningeal irritation but no focal
neurologic deﬁcits. A grade 4/6 systolic murmur
at the left sternal border and a grade 2/6 diastolic
murmur at the apex were noted. The tempera-
ture was 36.5 8C, the blood pressure was 140/
60mmHg, the pulse was 64/min, and the respira-
tory rate was 16/min. The results of skin, abdom-
inal and lung examination were unremarkable. A
contrast-enhanced computed tomographic (CT)
scan of the brain revealed a subarachnoid hemor-
rhage localized in the right temporoparietal
region. Four-vessel cerebral angiography demon-
strated the presence of an aneurysm at the right
communicans posterior artery. The results of an
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electrocardiogram and a chest roentgenogram
were interpreted as being normal. Transthoracic
echocardiography (TTE) documented moderate
aortic valve insufﬁciency and severe aortic valve
stenosis. No vegetations were seen. Laboratory
tests were notable for a hemoglobin concentration
of 11.5 g/dL, a leukocyte count of 19 600/mm3, a
sedimentation rate of 41mm/h, and a c-reative
protein concentration (CRP) of 2.3mg/dL. Liver
and renal function tests were normal, as was the
urinalysis.
The patient underwent neurosurgical trepana-
tion and clipping of the intracranial aneurysm. The
postoperative course was uncomplicated, apart
from the development of a subconjunctival hemor-
rhage. On day 20 of hospitalization, the patient
was discharged. However, 1 week later, she was
readmitted because of recurrence of severe head-
ache, followed by an epileptic insult with postictal
right hemiparesis and dysphasia. Physical exam-
ination revealed a pale and agitated girl. She was
hemodynamically stable. The temperature was
38.6 8C. The heart murmur was unchanged. A skin
rash and mild clubbing were present. She showed
good dental hygiene. She was being treated by an
orthodontist, but denied recent invasive dental
procedures. Compared with her ﬁrst admission,
no other abnormalities were noted. A repeat CT of
the brain conﬁrmed the presence of a new subar-
achnoid hemorrhage localized at the left parietal
region. Four-vessel cerebral angiography revealed
at least three bilateral intracranial aneurysms
(Figure 1). A repeat TTE showed similar ﬁndings
as the ﬁrst time. The hemoglobin concentration
was 9.2 g/dL, the leukocyte count 15 140/mm3,
and the CRP 13.4mg/dL. The diagnosis of intra-
cranial mycotic aneurysmswasmade, presumably
related to an episode of IE.
Four sets of blood cultures were taken over a 2-h
period. The blood cultures were incubated at 35 8C
using the Bactec 9240 system (Becton Dickinson,
Sparks, MD, USA) in aerobic and anaerobic bottles
(Bactec Plus Aerobic/F and Anaerobic/F, Becton
Dickinson). After 3 days of incubation, all of the
aerobic bottles became positive. Gram staining
revealed Gram-positive ﬁlamentous rods with
occasional branching. The bacterium was non-
motile and non-acid-fast. Subcultures on 5% sheep
blood agar yielded non-hemolytic, small, adher-
ent, dry white colonies after 24 h of aerobic incu-
bation at 35 8C. After prolonged incubation,
the colony surface became rough, with several
colonies showing a ‘spoked-wheel’ morphology.
No aerial mycelium was produced. On Triple
Sugar Iron agar, the bacterium had a mucoid
appearance and showed acidiﬁcation of both butt
and slant. The following biochemical reactions
were positive: catalase production, esculin hydro-
lysis, and nitrate reduction. Oxidase, urease, indol,
lysine and ornithine decarboxylase and gelatinase
production were negative. Carbohydrate-fermen-
tation reactions were positive for glucose, sucrose
andmaltose, but negative for lactose, mannitol and
xylose. Use of API CORYNE test strips (Biome´r-
ieux, Marcy l’Etoile, France) yielded code 7050125,
compatible with identiﬁcation of R. dentocariosa.
Analysis of the cellular fatty acid (CFA) composi-
tion (Microbial ID, Newark, NY, USA) revealed
that themajority of the CFAs comprised one of two
types: anteisopentadecanoic acid (Ca15 : 0) and
anteisoheptadecanoic acid (Ca17 : 0). Based on the
above described characteristics, the Laboratory of
Microbiology of the University Hospital Leuven
conﬁrmed the identiﬁcation of the bacterium as
R. dentocariosa. The minimal inhibitory concentra-
tions (MICs) for antimicrobial agents,measured on
horse blood agar using the gradient diffusion
method (E test, AB Biodisk, Solna, Sweden),
were: penicillin 0.008mg/L, cefotaxime 0.047mg/
L, clindamycin 0.75mg/L, vancomycin 1.5mg/L,
teicoplanin 0.75mg/L, and gentamicin 1.5mg/L.
Meanwhile, the patient was transferred to the
University Hospital Leuven, where transesopha-
geal echocardiography (TEE) demonstrated the
presence of a vegetation on the right leaﬂet of
the bicuspid aortic valve. An orthopantomogram
showed no dental decay. Treatment with intrave-
nous penicillin (24 million U/day) was started,
combined with amikacin (1 g/day) after a few
days. During this treatment, the patient developed
fever and some Janeway lesions on the forearms.
Fourteen sets of blood cultures were taken over a
20-day period, but yielded no growth of bacteria.
Because a routinely performed repeat TEE showed
the presence of an aortic root abscess after 1 week
of treatment, the patient underwent aortic valve
replacement. The valve was cultured and yield-
ed growth of coagulase-negative Staphylococcus,
probably due to contamination. One month after
treatment, the patient was doingwell. Repeat four-
vessel cerebral angiography showed that the intra-
cranial mycotic aneurysms had resolved. Nine
months after treatment, the patient still is doing
well.
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DISCUSSION
AMedLine search for R. dentocariosa IE revealed 19
cases [6–21]. These 19 cases and four new cases are
summarized in Table 1. In seven cases, no data
regarding the identiﬁcation of the bacterium were
shown [2,5–8,15,16]. In fact, in only ﬁve cases were
the date presented sufﬁcient to meet the minimal
microbiological requirements for publication on
disease associations of coryneform bacteria, as
proposed by Funke [4,10–13,22]. In contrast, all
19 cases met the Duke criteria for the deﬁnite or
possible diagnosis of IE [23].
Properties allowing presumptive identiﬁcation
of R. dentocariosa are presented in Table 2. R.
dentocariosa is a pleomorphic Gram-positive bac-
terium that varies in form from coccoid to irregular
rod-shaped to ﬁlamentous with possible branch-
ing. Growth is best with aerobic incubation at
35–37 8C. On 5% blood agar, the colonies are
white, mostly smooth and about 1mm in diameter
after 24 h of incubation (Figure 2). After prolonged
incubation, they become larger and rough, often
showing the characteristic spoked-wheel appear-
ance [2,22]. The API CORYNE test strips are useful
for identiﬁcation and typically yield codes 7050125
or 7052125 [24]. However, correct identiﬁcation of
R. dentocariosa can be difﬁcult, especially its differ-
entiation from Dermabacter hominis, Actinomyces
viscosus, Propionibacterium avidum, and Corynebac-
terium matruchotii. Chemotaxonomic investigation
(e.g. CFA chromatography) is recommended for
deﬁnite identiﬁcation ofR. dentocariosa [22,24]. IfR.
dentocariosa is not correctly identiﬁed in blood
cultures, but regarded as a contaminant coryne-
form bacterium, delay in diagnosis and appropri-
ate treatment is possible. This has been reported in
one case [10].
Various clinical features of R. dentocariosa IE are
summarized in Table 3. Of interest are the male
predominance (75%), the frequent presence of
prior heart conditions (85%), and the high rates
of major complications, both cardiac (50%) and
non-cardiac (40%). Thesemay be the consequences
of a more protracted course of IE caused by this
microorganism. Complications reported include
cardiac abscess, heart valve insufﬁciency, conges-
tive heart failure, mycotic aneurysms, brain
abscess, intracerebral hemorrhage, subarachnoid
hemorrhage, and vertebral osteomyelitis. Never-
theless, only three patients (15%) have died due
to complications. Two of these three patients
presented with a more acute form of disease. This
is illustrated by the reported time between the
onset of symptoms and the diagnosis of IE, which
was 5 days for these two patients, versus an overall
mean of 44 days. The third patient had a protracted
disease course, developed cardiac complications,
and died because of refusal to undergo cardiac
surgery.
Our case is remarkable for the occurrence of two
subarachnoid hemorrhages within 1 month due to
intracranial mycotic aneurysms. To our knowl-
edge, this is the ﬁrst reported case of R. dentocariosa
IE complicated by repeated subarachnoid hemor-
rhages. Our case brings the total amount of R.
dentocariosa IEs complicated by mycotic aneur-
ysms to 25% of reported cases. This is much
greater than the reported incidence of mycotic
aneurysms as complications of IE (3–5% of cases)
[23,25]. Intracranial mycotic aneurysms represent
only a fraction of reported mycotic aneurysms, but
they are probably underestimated because some
remain asymptomatic and resolve with antibiotic
therapy. Most intracranial mycotic aneurysms are
caused by streptococci and Staphylococcus aureus
and are localized to the distal middle cerebral
artery branches, as in the present case. Their
appearance at this locality is almost pathognomo-
nic for IE, since other cerebral aneurysms are
conﬁned to the greater vessels at the skull base.
Although most intracranial mycotic aneurysms
will heal with antibiotic treatment, some will pro-
gress in size and/or number and lead to rupture,
causing substantial morbidity or mortality. Treat-
ment decisions concerningmedical versus surgical
therapy have to be individualized. Frequent serial
angiograms are necessary, and prompt excision
is indicated upon enlargement or bleeding of a
(distal) intracranial mycotic aneurysm [25].
Although antimicrobial susceptibility data are
rare and no NCCLS protocols exist for testing of
susceptibility, the most frequently used antimicro-
bial therapy for R. dentocariosa IE is the combina-
tion of penicillin and gentamicin (45%). Strains of
R. dentocariosa tested in nine of 20 cases of IE have
shown a universally low penicillin MIC (range
0.008–0.12mg/L). An elevated gentamicin MIC
has been noted in two cases [13,15]. Although
no NCCLS susceptibility breakpoints for R. dento-
cariosa exist, the low penicillin MICs and the favor-
able outcome with penicillin therapy suggest in
vivo susceptibility of R. dentocariosa. Nevertheless,
disease progression in patients receiving proper
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antimicrobial therapy has been reported in eight
cases (40%). Of these eight patients, seven under-
went cardiac surgery; ﬁve were cured and two
died. This suggests that cardiac surgery has an
important place in the treatment of R. dentocariosa
IE, when antimicrobial therapy is ineffective.
In summary, IE caused by R. dentocariosa is
mostly a subacute process with low rates of mor-
tality, but with frequent cardiac and non-cardiac
complications. Among the latter, the reported inci-
dence of mycotic aneurysms is high (25%). The
universal susceptibility to penicillin makes this
Figure 1 Four-vessel cerebral angio-
graphy showing (arrows) a promi-
nent aneurysm on branches of the
left and right arteria cerebri media.
Table 2 Tests for the presumptive identification of Rothia dentocariosa [2,22,24]
Biochemical reactions
Morphology and colony appearance Enzyme production
Carbohydrate
fermentation
Non-motile Catalase: þ Glucose: þ
Gram-positive Esculin hydrolysis: þ Maltose: þ
Non-acid fast Nitrate reduction: þ Sucrose: þ
Coccoid, irregular rod-shaped or filamentous forms (branching) Urease: – Mannitol: –
Non-hemolytic, white, smooth to rough (spoked-wheel) Indole production: – Xylose: –
Grows best aerobically Alkaline phosphatase: – Ribose: –
b-Galactosidase: – Lactose: d
Pyrrolidonylarylamidase: þ
þ, 90% or more of strains positive; –, 90% or more of strains negative; d, 11–89% of strains positive.
Table 3 Clinical features of patients with Rothia dentocariosa endocarditis (n¼ 20)
Clinical feature Proportion of patients Percentage of patients
Mean age in years (range) 44.8 (6–71)
Female/male ratio 1 : 3
Prior heart condition 17/20 85%
Prior dental procedure/disease 12/20 60%
Fever (> 38 8C) 19/20 95%
Heart murmur 18/20 90%
Peripheral stigmata 10/20 50%
Echocardiographic findings consistent with infectious endocarditis 18/20 90%
Mean time from the onset of symptoms to diagnosis in days (range) 46 (5–334)
Major non-cardiac complicationa 8/20 40%
Cardiac complicationb 10/20 50%
Patients requiring cardiac surgery 8/20 40%
Death as outcome 3/20 15%
aBrain abscess, mycotic aneurysm, intracerebral hemorrhage, subarachnoid hemorrhage, vertebral osteomyelitis.
bCardiac abscess, heart valve insufficiency, congestive heart failure.
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antibiotic agent ﬁrst choice for therapy, but addi-
tional complications may necessitate prompt sur-
gical intervention.
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